• Alfuzosin HCl in Quantitative Assays: Precision Tools for BP

  2026-05-11

  Explore the advanced application of Alfuzosin HCl as a selective α1 adrenoceptor antagonist in quantitative assay development for benign prostatic hyperplasia research. This in-depth review reveals how optimized protocols and new reference insights can elevate experimental rigor.

• NF 340: Advancing P2Y11 Antagonist Applications in Cell Sign

  2026-05-10

  Explore how NF 340, a potent P2Y11 antagonist, enables advanced dissection of purinergic signaling pathways in cancer and immunology research. This article uniquely unpacks protocol design, mechanistic depth, and the translational impact of recent findings.

• Canagliflozin: Mitochondrial Remodeling in Renal Disease Res

  2026-05-09

  Canagliflozin, a potent SGLT2 inhibitor, is redefining experimental and translational paradigms in diabetes and kidney disease research. By integrating novel evidence on mitochondrial remodeling in proximal tubular cells, this article provides mechanistic insight, strategic protocol guidance, and a competitive landscape analysis—positioning APExBIO’s Canagliflozin as an essential tool for researchers looking beyond glucose-centric endpoints.

• ABT-263 (Navitoclax): Reprogramming Apoptosis for Metabolic

  2026-05-09

  Explore how ABT-263 (Navitoclax) enables precise apoptosis modulation in advanced cancer models by targeting Bcl-2 pathways and integrating metabolic insights. This article reveals unique assay strategies and interprets the latest metabolic rewiring research for oncology innovation.

• BRCAness and PARP Inhibitor Sensitivity in Mesothelioma

  2026-05-08

  Borchert et al. (2019) identify homologous recombination repair (HRR) gene expression patterns—termed 'BRCAness'—that predict susceptibility to PARP inhibition in malignant pleural mesothelioma (MPM). Their findings illuminate new molecular markers for therapy stratification and suggest that targeting HRR defects may enhance clinical management of MPM.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Advanced Use-Cas

  2026-05-07

  The One-step TUNEL Cy5 Apoptosis Detection Kit streamlines apoptosis detection with Cy5 fluorescence, enabling reproducible quantification in both tissue sections and cultured cells. Its robust, single-tube workflow empowers researchers to dissect programmed cell death in disease models and drug resistance studies with confidence.

• Novel qPCR Assay Distinguishes Exogenous M-MuLV in Mouse Cel

  2026-05-07

  Choi et al. (2025) introduce a real-time PCR method that accurately quantifies exogenous Moloney Murine Leukemia Virus (M-MuLV) in mouse cells, overcoming challenges posed by endogenous retroviral sequences. Their approach enables sensitive, rapid, and scalable viral quantification, facilitating research into retrovirus replication and pathogenesis.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pract

  2026-05-06

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) protects protein samples from degradation by endogenous proteases during extraction and preparation, while maintaining compatibility with workflows sensitive to divalent cations. It is not suitable for applications requiring metalloprotease inhibition via EDTA or for workflows incompatible with DMSO as a solvent.

• Saracatinib (AZD0530): Precision Inhibition for Cancer Biolo

  2026-05-06

  Saracatinib (AZD0530) enables highly selective, reproducible Src and Abl kinase inhibition, unlocking robust cancer cell proliferation and migration assays. With validated workflows and troubleshooting insights, this APExBIO reagent empowers researchers to dissect tumor signaling with confidence.

• Practical Use of the Bradford Protein Assay Kit (SKU: K4103)

  2026-05-05

  The Bradford Protein Assay Kit provides rapid, sensitive, and accurate quantification of protein concentrations in biochemical research workflows. It is particularly suitable for routine protein concentration measurement in enzyme assays, protein purification, and molecular biology studies. Researchers should avoid its use with samples containing detergents or chemicals known to interfere with Coomassie dye binding.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-05-05

  This study uncovers how certain kinase inhibitors, by stabilizing specific inactive conformations of the p38α MAP kinase activation loop, not only block kinase activity but also enhance its dephosphorylation by the WIP1 phosphatase. These findings support a novel dual-action mechanism, offering new avenues for designing kinase inhibitors with improved specificity and potency.

• HOXC8 Suppresses Lung Cancer Pyroptosis via Caspase-1 Regula

  2026-05-04

  The referenced study reveals that HOXC8, a homeobox transcription factor, restricts pyroptotic cell death in non-small cell lung carcinoma by repressing caspase-1 expression. This mechanistic insight uncovers a novel link between epigenetic regulation and inflammatory cell death, with potential implications for targeting tumor cell survival.

• LY2603618: Precision Chk1 Inhibitor for G2/M Cell Cycle Rese

  2026-05-04

  LY2603618 empowers researchers to dissect DNA damage response mechanisms with remarkable selectivity for Chk1. Its synergy with chemotherapeutics and redox modulators provides new avenues for sensitizing cancer cells in preclinical models, especially in non-small cell lung cancer research.

• RG108 DNA Methyltransferase Inhibitor: Applied Workflows & O

  2026-05-03

  RG108 is a potent DNA methyltransferase inhibitor uniquely suited for reversible epigenetic modulation in cancer and stem cell research. This article distills advanced workflows, key findings, and troubleshooting strategies, enabling researchers to maximize RG108’s specificity and demethylation power.

• Moderate BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-05-02

  Satir et al. (2020) demonstrate that partial inhibition of BACE1 using agents like LY2886721 can achieve significant amyloid-beta reduction without disrupting synaptic transmission. These findings inform Alzheimer's disease treatment research by emphasizing the importance of dosing strategies to maximize efficacy while minimizing adverse effects.

457 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page